Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bausch + Lomb Stock Pops
Why Bausch + Lomb Stock Soared by Over 7% on Monday
It was quite a busy and eventful day for the company.
Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid
Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company.
M&A News: TPG and Blackstone Could Eye Joint Bid for Bausch + Lomb (NYSE:BLCO)
Shares of contact lens supplier Bausch + Lomb ($BLCO) are surging in today’s trading amid news of a potential acquisition. According to an
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity firms TPG and Blackstone are joining forces in a bid to acquire eye care company Bausch + Lomb BLCO, the Financial Times reported. Last month, Bausch + Lomb said it was considering a sale.
Bausch & Lomb, enVista and Intraocular Lens
Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
Bausch + Lomb Shares Rise on FDA Approval of enVista Envy Intraocular Lens
Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at $21.03, hitting a new 52-week high.
Bausch + Lomb : FDA Approves EnVista Envy Full Range Of Vision Intraocular Lens
Bausch + Lomb Corp. (BLCO, BLCO.TO) announced that the U.S. Food and Drug Administration has approved the enVista Envy full range of
1d
on MSN
Bausch & Lomb gains amid report TPG, Blackstone working on joint bid
Bausch & Lomb (NYSE:BLCO) jumped 9% in premarket trading on a report that private equity firms TPG (TPG) and Blackstone (BX) ...
2d
Bausch Health Companies (NYSE:BHC shareholders incur further losses as stock declines 4.4% this week, taking three-year losses to 72%
Bausch Health Companies Inc. ( NYSE:BHC ) shareholders should be happy to see the share price up 26% in the last ...
FiercePharma
7d
Bausch + Lomb taps broadcaster Erin Andrews to push fast-growing dry eye disease drug
Bausch + Lomb has teamed up with American sportscaster Erin Andrews to promote its dry eye disease treatment, launching the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Town hall interrupted
MA town fines resident
GA must certify election
To close 1,200 US stores
Detroit off-duty officer killed
Inter-Korean roads blown up
2,471-pound pumpkin wins
Arrested for FEMA threats
Jacket to be auctioned
Signals caution on rate cuts
Signs gas price spikes law
AR casino challenge ruling
Meat items recall expands
Files for bankruptcy
Sign nuclear power deal
New reptile fossil found
Rapper Ka dies at 52
Settles gamers' antitrust suit
Sued by workers for injuries
Rare comet spotted
US troops arrive In Israel
ISR strikes Lebanon town
BCBS settles antitrust claims
IP theft in NASCAR
IDF finds Hezbollah bunker
Tech founder's murder trial
Arrests at the NYSE
COVID linked to diabetes?
Medicare open enrollment
Feedback